PRO-DEX INC (PDEX) Stock Fundamental Analysis
USA - NASDAQ:PDEX - US74265M2052 - Common Stock
30.34 USD
-0.12 (-0.39%)
30.34 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to PDEX. PDEX was compared to 188 industry peers in the Health Care Equipment & Supplies industry. PDEX has an excellent profitability rating, but there are some minor concerns on its financial health. PDEX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
PDEX had positive earnings in the past year.
PDEX had a negative operating cash flow in the past year.
PDEX had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PDEX reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of PDEX (17.41%) is better than 97.87% of its industry peers.
PDEX has a Return On Equity of 26.96%. This is amongst the best in the industry. PDEX outperforms 96.81% of its industry peers.
The Return On Invested Capital of PDEX (16.51%) is better than 96.28% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PDEX is significantly above the industry average of 8.98%.
The last Return On Invested Capital (16.51%) for PDEX is above the 3 year average (14.16%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROIC | 16.51% |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
1.3 Margins
PDEX has a Profit Margin of 15.94%. This is amongst the best in the industry. PDEX outperforms 90.96% of its industry peers.
In the last couple of years the Profit Margin of PDEX has declined.
PDEX's Operating Margin of 15.36% is amongst the best of the industry. PDEX outperforms 85.11% of its industry peers.
PDEX's Operating Margin has declined in the last couple of years.
The Gross Margin of PDEX (28.09%) is worse than 77.13% of its industry peers.
In the last couple of years the Gross Margin of PDEX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% |
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
2. Health
2.1 Basic Checks
PDEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, PDEX has less shares outstanding
Compared to 5 years ago, PDEX has less shares outstanding
Compared to 1 year ago, PDEX has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.84 indicates that PDEX is not in any danger for bankruptcy at the moment.
The Altman-Z score of PDEX (5.84) is better than 80.32% of its industry peers.
PDEX has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.21, PDEX perfoms like the industry average, outperforming 57.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.84 |
ROIC/WACC2
WACC8.27%
2.3 Liquidity
A Current Ratio of 3.73 indicates that PDEX has no problem at all paying its short term obligations.
PDEX has a better Current ratio (3.73) than 66.49% of its industry peers.
A Quick Ratio of 2.14 indicates that PDEX has no problem at all paying its short term obligations.
With a Quick ratio value of 2.14, PDEX perfoms like the industry average, outperforming 54.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.14%, which is quite impressive.
PDEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.96% yearly.
PDEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.65%.
The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.51, which indicates a very decent valuation of PDEX.
Based on the Price/Earnings ratio, PDEX is valued cheaper than 92.55% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.51. PDEX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 12.50 indicates a correct valuation of PDEX.
88.83% of the companies in the same industry are more expensive than PDEX, based on the Price/Forward Earnings ratio.
PDEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.51 | ||
| Fwd PE | 12.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 93.62% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.66 |
4.3 Compensation for Growth
PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.87
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
PDEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.34
-0.12 (-0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners32.91%
Inst Owner Change-3.05%
Ins Owners35.95%
Ins Owner Change0.01%
Market Cap99.52M
Revenue(TTM)70.23M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (88.27%)
Short Float %11.07%
Short Ratio4.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.51 | ||
| Fwd PE | 12.5 | ||
| P/S | 1.42 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.4 | ||
| P/tB | 2.4 | ||
| EV/EBITDA | 7.66 |
EPS(TTM)3.19
EY10.51%
EPS(NY)2.43
Fwd EY8%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS21.41
BVpS12.66
TBVpS12.65
PEG (NY)N/A
PEG (5Y)0.87
Graham Number30.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROCE | 21.27% | ||
| ROIC | 16.51% | ||
| ROICexc | 20.85% | ||
| ROICexgc | 20.86% | ||
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% | ||
| FCFM | N/A |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 73.12% | ||
| Cap/Sales | 1.3% | ||
| Interest Coverage | 12.57 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 5.84 |
F-Score6
WACC8.27%
ROIC/WACC2
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A
PRO-DEX INC / PDEX FAQ
Can you provide the ChartMill fundamental rating for PRO-DEX INC?
ChartMill assigns a fundamental rating of 5 / 10 to PDEX.
Can you provide the valuation status for PRO-DEX INC?
ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.
Can you provide the profitability details for PRO-DEX INC?
PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for PDEX stock?
The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.